-- Garuda, Indofood Sukses, Kalbe Farma: Indonesian Equity Preview
-- B y   B e r n i   M o e s t a f a
-- 2012-05-24T02:01:49Z
-- http://www.bloomberg.com/news/2012-05-24/garuda-indofood-sukses-kalbe-farma-indonesian-equity-preview.html
Shares of the following companies may
have  unusual  moves in  Indonesian trading . Stock symbols are in
parentheses, and share prices are as of the previous close.  The  Jakarta Composite index  fell 1 percent to 3,981.58.  Energy companies: Crude oil for July delivery dropped 2.1
percent to $89.90 a barrel in  New York  yesterday, erasing gains
through 2011. The contract was last at $90.79 in after-hours
trading.  PT Medco Energi Internasional (MEDC)  , Indonesia’s
biggest listed oil company, lost 1.6 percent to 1,900 rupiah and
 PT Energi Mega Persada (ENRG)  , the second largest, sank 5.9
percent to 161 rupiah.  PT Garuda Indonesia (GIAA)  : The national flag carrier
signed a preliminary  agreement with Accor SA, Europe’s biggest
hotel operator, to help attract more passengers, Bisnis
Indonesia reported, citing Garuda President Director Emirsyah Satar. The agreement will allow Accor’s members to buy Garuda
tickets at discounts, the report said. Garuda declined 1.4
percent to 710 rupiah.  PT Indofood Sukses Makmur (INDF)  : The parent company of
Indonesia’s largest instant noodle maker will sell 2 trillion
rupiah ($216 million) of five-year bonds with a coupon rate of
7.25 percent this month, it said in a statement published in
Bisnis Indonesia. Indofood rose 1.1 percent to 4,775 rupiah.  PT Kalbe Farma (KLBF)  : Indonesia’s biggest drug maker
set aside between 500 billion rupiah and 1 trillion rupiah to
finance acquisitions of pharmaceutical and nutritional product
makers, the Jakarta Post reported, citing Director Vidjongtius.
Kalbe also plans a stock split with a ratio of five-for-one, the
report said. The stock was unchanged at 3,900 rupiah.  To contact the reporter on this story:
Berni Moestafa in Jakarta at 
 bmoestafa@bloomberg.net   To contact the editor responsible for this story:
Darren Boey at   dboey@bloomberg.net  